Prevalence and Treatment of Diabetes in China, 2013-2018

Datos Bibliográficos

ID23323695
AutoresLimin Wang (0000-0001-9618-9239, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Wen Peng (0000-0002-7939-676X, Nutrition and Health Promotion Center, Department of Public Health, Medical College, Qinghai University, Xining, China), Zhenping Zhao (0000-0003-4227-3034, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Mei Zhang (0000-0001-9803-0205, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Zumin Shi (0000-0002-3099-3299, Qatar University), Ziwei Song (0000-0003-1782-0227, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Xiao Zhang (0000-0002-0342-3282, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Chun Li (0000-0001-7981-7184, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Zhengjing Huang (National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Xiaomin Sun (0000-0002-2773-7761, Global Health Institute, Xi’an Jiaotong University, Xi’an, China), Linhong Wang (0000-0002-6418-1520, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Lınhong Wang (0000-0002-9541-3654, National Center for Chronic and Noncommunicable Disease Control and Prevention), Maigeng Zhou (0000-0001-6402-6347, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China), Jing Wu (0000-0002-6559-4335, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China, autor de correspondencia), Youfa Wang (0000-0002-6041-6011, Global Health Institute, Xi’an Jiaotong University, Xi’an, China, autor de correspondencia)
Año2021
Volumen326
Número24
Páginas2498
Fecha de publicación2021-12-28
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaJAMA (JOURNAL)
Identificadores de la revistaISSN: 0098-7484 • E-ISSN: 1538-3598
EditorialAmerican Medical Association (AMA) (PUBLISHER)
DOI10.1001/jama.2021.22208
PMID34962526
OpenAlexW4200230313
IdiomaEN
Citas recibidas79
Referencias citadas21

Importance: Recent data on prevalence, awareness, treatment, and risk factors of diabetes in China is necessary for interventional efforts. Objective: To estimate trends in prevalence, awareness, treatment, and risk factors of diabetes in China based on national data. Design, Setting, and Participants: Cross-sectional nationally representative survey data collected in adults aged 18 years or older in mainland China from 170 287 participants in the 2013-2014 years and 173 642 participants in the 2018-2019 years. Exposures: Fasting plasma glucose and hemoglobin A1c levels were measured for all participants. A 2-hour oral glucose tolerance test was conducted for all participants without diagnosed diabetes. Main Outcomes and Measures: Primary outcomes were diabetes and prediabetes defined according to American Diabetes Association criteria. Secondary outcomes were awareness, treatment, and control of diabetes and prevalence of risk factors. A hemoglobin A1c level of less than 7.0% (53 mmol/mol) among treated patients with diabetes was considered adequate glycemic control. Results: In 2013, the median age was 55.8 years (IQR, 46.4-65.2 years) and the weighted proportion of women was 50.0%; in 2018, the median age was 51.3 years (IQR, 42.1-61.6 years), and the weighted proportion of women was 49.5%. The estimated prevalence of diabetes increased from 10.9% (95% CI, 10.4%-11.5%) in 2013 to 12.4% (95% CI, 11.8%-13.0%) in 2018 (P < .001). The estimated prevalence of prediabetes was 35.7% (95% CI, 34.2%-37.3%) in 2013 and 38.1% (95% CI, 36.4%-39.7%) in 2018 (P = .07). In 2018, among adults with diabetes, 36.7% (95% CI, 34.7%-38.6%) reported being aware of their condition, and 32.9% (95% CI, 30.9%-34.8%) reported being treated; 50.1% (95% CI, 47.5%-52.6%) of patients receiving treatment were controlled adequately. These rates did not change significantly from 2013. From 2013 to 2018, low physical activity, high intake of red meat, overweight, and obesity significantly increased in prevalence. Conclusions and Relevance: In this survey study, the estimated diabetes prevalence was high and increased from 2013 to 2018. There was no significant improvement in the estimated prevalence of adequate treatment.

Cross-sectional study · Diabetes mellitus · Glycemic · Prediabetes · Type 2 diabetes · Diabetes, Cardiovascular Risks, and Lipoproteins · Endocrinology · Internal Medicine · Medicine · Metabolism, Diabetes, and Cancer · Neurological Disease Mechanisms and Treatments · Pediatrics